AT
Insider
Adam Taich
Chief Financial OfficerAdam Taich (Chief Financial Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in 10x Genomics, Inc. (TXG). The largest single filing was $2.9M of TXG (45,182 sh across 2 lots, as filed), executed Sep 9.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.8M
shares × price, as filed
Last traded
Sep 9
Filed Sep 11
Median ADV $190.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
5 filings
Sector per market data · by filing · past 12 months
Most traded names
TXGRecent filings
TXGSALE
10x Genomics, Inc.
View filing →
$2.9M45,182 sh across 2 lots
Exec Sep 9
Filed Sep 11 · 4:47 PM ET TXGSALE 10x Genomics, Inc. View filing → $1.1M
17,166 sh × $63.02
Exec Aug 24
Filed Aug 26 · 4:44 PM ET TXGSALE 10x Genomics, Inc. View filing → $369K
15,098 sh × $24.44
Exec May 22
Filed May 27 · 5:30 PM ET TXGSALE 10x Genomics, Inc. View filing → $167K
8,968 sh × $18.58
Exec Feb 23
Filed Feb 25 · 5:30 PM ET TXGSALE 10x Genomics, Inc. View filing → $226K
11,888 sh × $19.00
Exec Nov 24 2025
Filed Nov 25 2025 · 5:30 PM ET TXGSALE 10x Genomics, Inc. View filing → $308K
22,315 sh × $13.79
Exec Aug 22 2025
Filed Aug 26 2025 · 5:30 PM ET